These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15735005)

  • 21. KLF6 IVS1 -27G>A variant and the risk of prostate cancer in Finland.
    Seppälä EH; Autio V; Duggal P; Ikonen T; Stenman UH; Auvinen A; Bailey-Wilson JE; Tammela TL; Schleutker J
    Eur Urol; 2007 Oct; 52(4):1076-81. PubMed ID: 17125911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.
    Reeves HL; Narla G; Ogunbiyi O; Haq AI; Katz A; Benzeno S; Hod E; Harpaz N; Goldberg S; Tal-Kremer S; Eng FJ; Arthur MJ; Martignetti JA; Friedman SL
    Gastroenterology; 2004 Apr; 126(4):1090-103. PubMed ID: 15057748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
    DiFeo A; Feld L; Rodriguez E; Wang C; Beer DG; Martignetti JA; Narla G
    Cancer Res; 2008 Feb; 68(4):965-70. PubMed ID: 18250346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.
    Jeng YM; Hsu HC
    Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.
    Lièvre A; Landi B; Côté JF; Veyrie N; Zucman-Rossi J; Berger A; Laurent-Puig P
    Oncogene; 2005 Nov; 24(48):7253-6. PubMed ID: 16044160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.
    Lang UE; Kocabayoglu P; Cheng GZ; Ghiassi-Nejad Z; Muñoz U; Vetter D; Eckstein DA; Hannivoort RA; Walsh MJ; Friedman SL
    Oncogene; 2013 Sep; 32(38):4557-64. PubMed ID: 23085750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of KLF6 and its splice variant KLF6V on proliferation and differentiation of human hepatocellular carcinoma HepG2 cells].
    Pan XC; Chen Z; Ji F; Guo ZS; Chen M; Fu JJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):683-7. PubMed ID: 18822210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-i regulates Kruppel-like factor-6 gene expression in a p53-dependent manner.
    Bentov I; Narla G; Schayek H; Akita K; Plymate SR; LeRoith D; Friedman SL; Werner H
    Endocrinology; 2008 Apr; 149(4):1890-7. PubMed ID: 18174288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.
    Gehrau RC; D'Astolfo DS; Andreoli V; Bocco JL; Koritschoner NP
    Mutat Res; 2011 Feb; 707(1-2):15-23. PubMed ID: 21147133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
    Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
    J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
    Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
    Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.
    Kimmelman AC; Qiao RF; Narla G; Banno A; Lau N; Bos PD; Nuñez Rodriguez N; Liang BC; Guha A; Martignetti JA; Friedman SL; Chan AM
    Oncogene; 2004 Jun; 23(29):5077-83. PubMed ID: 15064720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes.
    Mühlbauer KR; Gröne HJ; Ernst T; Gröne E; Tschada R; Hergenhahn M; Hollstein M
    Br J Cancer; 2003 Aug; 89(4):687-90. PubMed ID: 12915879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
    Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
    Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
    Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
    RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of KLF6-SV2 in colorectal cancer and its impact on proliferation and apoptosis.
    Zhang B; Guo DD; Zheng JY; Wu YA
    Eur J Cancer Prev; 2018 Jan; 27(1):20-26. PubMed ID: 29084019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
    Zhang D; Li Z; Zhang Y; Tu C; Huo J; Liu Y
    Oncol Rep; 2016 Dec; 36(6):3657-3663. PubMed ID: 27779691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.